Metabolomics Study of Resina Draconis on Myocardial Ischemia Rats Using Ultraperformance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry Combined with Pattern Recognition Methods and Metabolic Pathway Analysis
Open Access
- 1 January 2013
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-10
Abstract
Resina draconis (bright red resin isolated fromDracaena cochinchinensis, RD) has been clinically used for treatment of myocardial ischemia (MI) for many years. However, the mechanisms of its pharmacological action on MI are still poorly understood. This study aimed to characterize the plasma metabolic profiles of MI and investigate the mechanisms of RD on MI using ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry-based metabolomics combined with pattern recognition methods and metabolic pathway analysis. Twenty metabolite markers characterizing metabolic profile of MI were revealed, which were mainly involved in aminoacyl-tRNA biosynthesis, phenylalanine, tyrosine, and tryptophan biosynthesis, vascular smooth muscle contraction, sphingolipid metabolism, and so forth. After RD treatment, however, levels of seven MI metabolite markers, including phytosphingosine, sphinganine, acetylcarnitine, cGMP, cAMP, L-tyrosine, and L-valine, were turned over, indicating that RD is likely to alleviate MI through regulating the disturbed vascular smooth muscle contraction, sphingolipid metabolism, phenylalanine metabolism, and BCAA metabolism. To our best knowledge, this is the first comprehensive study to investigate the mechanisms of RD for treating MI, from a metabolomics point of view. Our findings are very valuable to gain a better understanding of MI metabolic profiles and provide novel insights for exploring the mechanisms of RD on MI.Keywords
Funding Information
- National Natural Science Foundation of China (30901981, 21005015, 2011YQ170067)
- National Natural Science Foundation of China (30901981, 21005015, 2011YQ170067)
- Chinese National Instrumentation Program (30901981, 21005015, 2011YQ170067)
This publication has 37 references indexed in Scilit:
- NMR in Metabolomics and Natural Products Research: Two Sides of the Same CoinAccounts of Chemical Research, 2011
- Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition researchMetabolomics, 2009
- Sphingomyelinases: their regulation and roles in cardiovascular pathophysiologyCardiovascular Research, 2009
- Effect of stress adaptation on cyclic nucleotide content in myocardial tissue during acute ischemia/reperfusionBulletin of Experimental Biology and Medicine, 2008
- Sphingolipid therapy in myocardial ischemia–reperfusion injuryBiochimica et Biophysica Acta (BBA) - General Subjects, 2008
- Metabonomics: a platform for studying drug toxicity and gene functionNature Reviews Drug Discovery, 2002
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999
- Early hemodynamic effects at rest with acute and chronic isosorbide dinitrate treatment in patients with ischemic heart diseaseClinical Cardiology, 1995
- Phosphatidylcholine metabolism in ischemic and hypoxic heartsMolecular and Cellular Biochemistry, 1992
- Sphingolipid Metabolism in Organotypic Mouse Keratinocyte CulturesJournal of Investigative Dermatology, 1990